Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
4.745
+0.025 (0.53%)
May 14, 2026, 11:45 AM EDT - Market open
Verastem Employees
Verastem had 102 employees as of December 31, 2025. The number of employees increased by 24 or 30.77% compared to the previous year.
Employees
102
Change (1Y)
24
Growth (1Y)
30.77%
Revenue / Employee
$486,127
Profits / Employee
-$1,901,559
Market Cap
416.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 102 | 24 | 30.77% |
| Dec 31, 2024 | 78 | 5 | 6.85% |
| Dec 31, 2023 | 73 | 16 | 28.07% |
| Dec 31, 2022 | 57 | 9 | 18.75% |
| Dec 31, 2021 | 48 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Rocket Pharmaceuticals | 202 |
| Invivyd | 122 |
| Enanta Pharmaceuticals | 120 |
| C4 Therapeutics | 104 |
| Century Therapeutics | 78 |
| Larimar Therapeutics | 71 |
| PureTech Health | 56 |
VSTM News
- 3 hours ago - Verastem price target lowered to $14 from $16 at Mizuho - TheFly
- 2 days ago - Verastem Oncology to Present at Upcoming Investor Conferences - Business Wire
- 6 days ago - Verastem price target lowered to $18 from $19 at BTIG - TheFly
- 6 days ago - On World Ovarian Cancer Day, LGSOC Resource Guide Launches to Support People Living with Low-Grade Serous Ovarian Cancer - Business Wire
- 6 days ago - Verastem price target raised to $18 from $16 at Alliance Global - TheFly
- 6 days ago - Verastem reports Q1 adjusted EPS (43c), consensus (47c) - TheFly
- 6 days ago - Verastem Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Verastem Oncology Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates - Business Wire